Cannabis Use and Prospective Long-Term Association with Anxiety: A Systematic Review and Meta-Analysis of Longitudinal Studies: Usage du cannabis et association prospective à long terme avec l'anxiété: une revue systématique et une méta-analyse d'études longitudinales.
anxiety
cannabis use disorders
cohort study
meta-analysis
systematic reviews
Journal
Canadian journal of psychiatry. Revue canadienne de psychiatrie
ISSN: 1497-0015
Titre abrégé: Can J Psychiatry
Pays: United States
ID NLM: 7904187
Informations de publication
Date de publication:
02 2021
02 2021
Historique:
pubmed:
11
9
2020
medline:
19
8
2021
entrez:
10
9
2020
Statut:
ppublish
Résumé
Cannabis use is proposed as a risk factor for psychosis and is associated with depressive disorders. However, the relationship between recreational cannabis use and its longitudinal implications on anxiety conditions is less studied. The aim of this investigation is to systematically evaluate published literature and perform a meta-analysis of the data. A systematic search was performed of MEDLINE, Embase, and PsychINFO from inception to May 31, 2020, in addition to a hand search. Longitudinal studies that evaluated the relationship of cannabis use and development of anxiety were included. Where applicable, adjusted odds ratios ( After screening of unique abstracts ( Published evidence suggests that cannabis use is likely associated with increased risk of anxiety in the long term but variability of study designs precludes declaration of a causal relationship. Awareness of this association is of relevance for both clinical practice and mental health policy implementation.
Identifiants
pubmed: 32909828
doi: 10.1177/0706743720952251
pmc: PMC7918873
doi:
Types de publication
Journal Article
Meta-Analysis
Research Support, Non-U.S. Gov't
Systematic Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
126-138Références
Stat Med. 2002 Jun 15;21(11):1539-58
pubmed: 12111919
Lancet. 2007 Jul 28;370(9584):319-28
pubmed: 17662880
Neurotherapeutics. 2015 Oct;12(4):825-36
pubmed: 26341731
Hum Psychopharmacol. 2009 Oct;24(7):515-23
pubmed: 19693792
Dev Psychopathol. 2004 Fall;16(4):1007-27
pubmed: 15704825
JAMA Pediatr. 2017 Feb 1;171(2):116-118
pubmed: 28027335
J Psychopharmacol. 2012 Jan;26(1):177-88
pubmed: 21768160
Control Clin Trials. 1986 Sep;7(3):177-88
pubmed: 3802833
J Abnorm Child Psychol. 1996 Aug;24(4):499-512
pubmed: 8886945
J Subst Abuse Treat. 2017 Oct;81:53-58
pubmed: 28847455
J Psychopharmacol. 2005 Mar;19(2):187-94
pubmed: 15871146
Schizophr Bull. 2016 Sep;42(5):1262-9
pubmed: 26884547
Health Rep. 2019 Jun 19;30(6):3-13
pubmed: 31216047
Am J Drug Alcohol Abuse. 2017 Jul;43(4):442-455
pubmed: 27612527
Psychol Addict Behav. 2015 Sep;29(3):552-63
pubmed: 26237286
Subst Use Misuse. 2019;54(2):271-281
pubmed: 30395775
Alcohol Alcohol. 2011 Mar-Apr;46(2):192-9
pubmed: 21245062
Drug Alcohol Depend. 2007 Apr;88 Suppl 1:S60-70
pubmed: 17257779
Eur Neuropsychopharmacol. 2016 Mar;26(3):493-505
pubmed: 26775742
Drug Alcohol Depend. 2019 Nov 1;204:107499
pubmed: 31479864
Psychopharmacology (Berl). 2008 Aug;199(2):223-30
pubmed: 18446323
Addiction. 2013 Jan;108(1):124-33
pubmed: 22775447
J Nerv Ment Dis. 2006 Dec;194(12):958-61
pubmed: 17164636
Neurochem Res. 2005 Aug;30(8):1037-43
pubmed: 16258853
Addiction. 2007 Aug;102(8):1251-60
pubmed: 17624975
Addict Biol. 2017 Jul;22(4):1081-1089
pubmed: 26860734
Psychopharmacology (Berl). 1991;103(1):91-4
pubmed: 1672463
J Epidemiol Community Health. 2017 Aug;71(8):811-816
pubmed: 28053188
J Affect Disord. 2016 Mar 15;193:103-8
pubmed: 26773900
BMJ. 2006 Sep 16;333(7568):597-600
pubmed: 16974018
BMJ. 1997 Sep 13;315(7109):629-34
pubmed: 9310563
J Am Acad Child Adolesc Psychiatry. 1998 Mar;37(3):322-30
pubmed: 9519638
BMC Psychiatry. 2014 May 10;14:136
pubmed: 24884989
Depress Anxiety. 2017 Nov;34(11):1006-1017
pubmed: 28636769
PLoS One. 2015 Apr 13;10(4):e0122896
pubmed: 25875443
Int J Drug Policy. 2020 Feb 26;77:102698
pubmed: 32113149
Dtsch Arztebl Int. 2015 Apr 17;112(16):271-8
pubmed: 25939318
Psychol Rep. 2011 Apr;108(2):339-57
pubmed: 21675549
JAMA Psychiatry. 2019 Apr 1;76(4):426-434
pubmed: 30758486
Addiction. 2019 Oct;114(10):1889-1890
pubmed: 31256420
Addict Behav. 2018 Mar;78:107-113
pubmed: 29149635
Cell Commun Signal. 2010 Jun 17;8:12
pubmed: 20565726
J Clin Epidemiol. 2001 Oct;54(10):1046-55
pubmed: 11576817
J Psychoactive Drugs. 2012 Nov-Dec;44(5):381-9
pubmed: 23457889
J Psychiatr Res. 2008 Oct;42(12):1017-23
pubmed: 18076905
J Psychopharmacol. 2011 Jan;25(1):121-30
pubmed: 20829306
Am J Psychiatry. 1985 Jul;142(7):848-50
pubmed: 3874559
J Clin Pharmacol. 2019 Jul;59(7):923-934
pubmed: 30730563
Biol Psychiatry. 2016 Apr 1;79(7):613-9
pubmed: 26903403
JAMA Psychiatry. 2020 Oct 1;77(10):1044-1051
pubmed: 32459328
Psychol Med. 2014 Mar;44(4):797-810
pubmed: 23795762
Addiction. 1997 Mar;92(3):279-96
pubmed: 9219390
Curr Psychiatry Rep. 2015 Feb;17(2):4
pubmed: 25617040
Drug Alcohol Depend. 2012 Oct 1;125(3):267-75
pubmed: 22464050
Drug Alcohol Depend. 2017 Oct 1;179:109-116
pubmed: 28763778
J Stud Alcohol Drugs. 2016 Nov;77(6):889-897
pubmed: 27797690
Can J Psychiatry. 2019 May;64(5):304-312
pubmed: 30373388
PLoS One. 2011;6(12):e28668
pubmed: 22163051